To sell a natural health product (NHP) in Canada, companies must consider both product licensing and site licensing requirements. A product licence authorizes the sale of a specific NHP, while a site licence is required for the Canadian physical site where NHPs are manufactured, packaged, labelled, or imported for sale. Obtaining these licences requires regulated parties to demonstrate that the product meets applicable safety, efficacy, and quality requirements, and that licensable site activities are conducted in accordance with the good manufacturing practices (GMP) requirements set out in the Natural Health Products Regulations. Health Canada requires Canadian sites that manufacture, package, label, or import NHPs for sale to hold a valid site licence and comply with applicable GMP requirements. However, regulatory responsibility does not end once the licences are issued. NHP site licence holders must maintain compliance, renew their site licences, and be prepared for Health Canada inspections that assess whether…
On March 30, 2026, Health Canada has introduced an important operational change for Natural Health Product (NHP) site licence submissions. Through Natural Health Products Site Licensing and Good Manufacturing Practices Inspection Bulletin No. 11, the Health Product Compliance Directorate confirmed that it is transitioning away from ePost Connect and moving all site licence submission activities to LiquidFiles. While this update is procedural rather than legislative, it has immediate implications for regulatory teams, Quality Assurance Persons (QAP), importers, manufacturers, and any company responsible for maintaining an active NHP site licence under Part 2 of the Natural Health Products Regulations. As site licensing is foundational to legal market access in Canada, failure to adapt to the new submission process could result in rejected renewals, delayed amendments, missed notifications, or disruptions to ongoing…
All Natural Health Product (NHP) site licence holders in Canada must renew their licence in accordance with the Natural Health Products Regulations. Although the renewal term varies by licence and is assigned directly by Health Canada, the obligation remains consistent across all sites: confirm continued compliance with Part 3 Good Manufacturing Practices (GMP) and keep Health Canada’s site and foreign-site information current for all regulated activities. As site licence holders move toward their renewal date, the process shifts from a routine administrative requirement to a structured review of how the quality system has performed since the previous term. This includes validating site information, confirming GMP evidence, reviewing foreign-site documentation, and completing the Harmonized Site Licence and FSRN Application Form (webSLA) to reflect the present state of operations. In this article, we will examine the renewal requirements, the documentation expected by Health Canada,…
When Health Canada released Version 4.0 of the Good manufacturing practices guide for natural health products (GUI-0158) on September 4, 2025, it marked the first major revision of good manufacturing practices (GMP) expectations in a decade. The new guide, which will become enforceable on March 4, 2026, following a six-month transition period, does much more than update the language and structure of the previous document. It completely redefines how Natural Health Products (NHPs) are regulated in Canada by shifting the focus from procedural compliance to full-scale quality system accountability throughout the global supply chain. For importers and site licence holders, the changes are significant. It is no longer enough to confirm that a foreign manufacturer claims to meet GMP requirements. Canadian importers must now prove compliance through documented systems, validated…
Please note that Health Canada officially ended the Foreign Site Reference Number (FSRN) process on February 16, 2026. The Department determined that the mechanism was no longer necessary and has consolidated the review of foreign site Good Manufacturing Practices (GMP) evidence within the existing site licensing pathway. Any new FSRN applications are now rejected, and previously issued numbers are listed as discontinued. When foreign facilities manufacture, package, or label Natural Health Products (NHPs) for the Canadian market, Health Canada requires proof of Good Manufacturing Practices (GMP) compliance. To simplify this process and reduce administrative duplication, the Natural and Non-prescription Health Products Directorate (NNHPD) issues a Foreign Site Reference Number (FSRN). An FSRN acts as pre-cleared GMP evidence that Canadian importers can reference in their site licence applications. It protects confidential…
Please note that Health Canada officially ended the Foreign Site Reference Number (FSRN) process on February 16, 2026. The Department determined that the mechanism was no longer necessary and has consolidated the review of foreign site Good Manufacturing Practices (GMP) evidence within the existing site licensing pathway. Any new FSRN applications are now rejected, and previously issued numbers are listed as discontinued. When foreign facilities manufacture, package, or label Natural Health Products (NHPs) for the Canadian market, Health Canada requires proof that these sites meet Good Manufacturing Practices (GMPs). To simplify this process, the Natural and Non-prescription Health Products Directorate (NNHPD) issues a Foreign Site Reference Number (FSRN). An FSRN acts as pre-cleared GMP evidence that can be referenced by Canadian importers in their site licence applications, reducing duplication and…
In Canada, any business that manufactures, packages, labels, or imports natural health products (NHPs) must hold a valid site licence obtained from Health Canada. This licence confirms that the company complies with the requirements set out in the Natural Health Products Regulations and Site Licensing Guidance Document, including adherence to Good Manufacturing Practices (GMP) and associated regulations. A site licence ensures that NHPs are handled in a safe, sanitary, and controlled environment, providing assurance to both regulators and consumers. It is a crucial step for companies seeking to sell NHPs in Canada, as it supports regulatory compliance and helps avoid operational disruptions. Understanding the site licensing process is essential for smooth and successful market entry and ongoing business operations. What is an NHP Site Licence? A natural health product (NHP)…
Health Canada’s draft revised Natural Health Product (NHP) Quality Guide signals a shift toward lifecycle quality oversight for NHPs, with greater attention to specifications, stability, supplier controls, quality agreements and post-licensing documentation. Source Nutraceutical, Inc. (SNI) helps NHP brands understand what these proposed changes could mean in practice and how to prepare without overcorrecting before the final guide is published. Health Canada’s Draft NHP Quality Guide Health Canada has released a draft revised Quality of Natural Health Products Guide that could significantly change how NHP companies manage quality in Canada. The current guide, published in 2015, is largely focused on establishing product specifications and supporting Natural Product Number (NPN) applications. The proposed 2026 guide takes a broader approach by treating quality as an ongoing responsibility that extends across the full product lifecycle. For NHP brands, the draft guide reinforces that obtaining…
Obtaining a Natural Product Number (NPN) in Canada typically takes approximately 60 calendar days for Class I applications, 90 calendar days for Class II applications, and 270 or more calendar days for Class III applications. Due to current review backlogs, companies submitting Class III applications should plan for timelines closer to one year and ensure that Canadian manufacturing, sales, and active site licence information are accurately disclosed to support Health Canada's workload prioritization efforts. Source Nutraceutical, Inc. (SNI) supports companies throughout the NPN process, from product classification and application preparation to submission strategy and regulatory support. Introduction A product label may be almost finalized, inventory may be ready, and a retailer may already be asking for a launch date. However, if a natural health product (NHP) does not yet have a Natural Product…
As another quarter unfolds, we are pleased to share a curated selection of updates, insights, and resources to help keep you informed and connected. In this issue, you’ll find the latest happenings in the Natural Health Product (NHP) space, U.S. FDA updates, and upcoming events you won’t want to miss. TRADESHOW reCAP Where has SNI been lately? SNI had a busy and rewarding event season, attending Alimentaria Barcelona, AAD Annual Meeting, CHFA West, Natural Products Expo West, and WCG MAGI Clinical Research Conference. It was great reconnecting with our clients and meeting a strong mix of new and emerging brands across categories, all bringing fresh ideas and momentum into the market. Across the board, conversations focused on innovation, North American expansion, and the importance of getting regulatory, clinical, and commercial…
